(Q37631959)

21 August 2017

1 reference

title

Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria (English)

1 reference

21 August 2017

0 references

1 reference

1

1 reference

21 August 2017

James B Leverenz

8

0 references

Irene Litvan

object named as

Irene Litvan

11

0 references

Glenda Halliday

object named as

Glenda M Halliday

6

0 references

Thomas Gasser

5

object named as

Thomas Gasser

1 reference

21 August 2017

10

Zbigniew K Wszolek

1 reference

21 August 2017

7

John Hardy

1 reference

21 August 2017

4

Charles Duyckaerts

1 reference

21 August 2017

Heiko Braak

2

1 reference

PubMed ID

19909913

21 August 2017

John E Duda

3

1 reference

PubMed ID

19909913

21 August 2017

Kelly Del Tredici

9

1 reference

21 August 2017

1 December 2009

1 reference

21 August 2017

1 reference

21 August 2017

8

1 reference

21 August 2017

12

1 reference

21 August 2017

1150-1157

1 reference

Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium

21 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

Basic research on dopamine in Parkinson's disease and the discovery of the nigrostriatal dopamine pathway: the view of an eyewitness

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

Ageing and Parkinson's disease: substantia nigra regional selectivity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

Motor score of the Unified Parkinson Disease Rating Scale as a good predictor of Lewy body-associated neuronal loss in the substantia nigra.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

Nomenclature for neuropathologic subtypes of frontotemporal lobar degeneration: consensus recommendations

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

DCTN1 mutations in Perry syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

Lewy bodies and parkinsonism in families with parkin mutations

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

Lewy body Parkinson's disease in a large pedigree with 77 Parkin mutation carriers

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

Familial parkinsonism: study of original Sagamihara PARK8 (I2020T) kindred with variable clinicopathologic outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

Update on the genetics of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

Nosology of Parkinson's disease: looking for the way out of a quagmire

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

Mixed brain pathologies in dementia: the BrainNet Europe consortium experience

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

Colocalization of Tau and Alpha-Synuclein Epitopes in Lewy Bodies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

Autosomal recessive early-onset parkinsonism with diurnal fluctuation: clinicopathologic characteristics and molecular genetic identification.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

Pathologic and biochemical studies of juvenile parkinsonism linked to chromosome 6q.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

Alpha-synuclein in Lewy bodies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

Extensive axonal Lewy neurites in Parkinson's disease: a novel pathological feature revealed by alpha-synuclein immunocytochemistry

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

Accumulation of phosphorylated alpha-synuclein in aging human brain.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

Lewy body in neurodegeneration with brain iron accumulation type 1 is immunoreactive for alpha-synuclein.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

Neurodegeneration with brain iron accumulation, type 1 is characterized by alpha-, beta-, and gamma-synuclein neuropathology

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

Assessment of α-Synuclein Pathology: A Study of the BrainNet Europe Consortium

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

Evaluation of alpha-synuclein immunohistochemical methods used by invited experts

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

Comparative study of commercially available anti-alpha-synuclein antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

Multiple-system atrophy: a new alpha-synuclein disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

Parkinson's disease, dementia with Lewy bodies and multiple system atrophy are alpha-synucleinopathies.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

Analysis of the adrenal gland is useful for evaluating pathology of the peripheral autonomic nervous system in lewy body disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

Lewy body pathology involves cutaneous nerves.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

Staging of brain pathology related to sporadic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

Alpha-synuclein pathology of the spinal and peripheral autonomic nervous system in neurologically unimpaired elderly subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

Differences in neuropathologic characteristics across the Lewy body dementia spectrum.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

Patterns and stages of alpha-synucleinopathy: Relevance in a population-based cohort.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

The progression of pathology in longitudinally followed patients with Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

Applicability of current staging/categorization of alpha-synuclein pathology and their clinical relevance

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

Diagnostic criteria for Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

Morphometry of the human substantia nigra in ageing and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

Empiric refinement of the pathologic assessment of Lewy-related pathology in the dementia patient

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

Staging/typing of Lewy body related alpha-synuclein pathology: a study of the BrainNet Europe Consortium.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

The morphological basis of mental dysfunction in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

Does striatal pathology distinguish Parkinson disease with dementia and dementia with Lewy bodies?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

Are Parkinson's disease with dementia and dementia with Lewy bodies the same entity?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

Relationship between Parkinson disease with dementia and dementia with Lewy bodies.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

Dementia with Lewy bodies and Parkinson's disease with dementia: are they different?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

Lewy body-type degeneration in cardiac plexus in Parkinson's and incidental Lewy body diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

Parkinsonian signs and substantia nigra neuron density in decendents elders without PD

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

Lewy body pathology in normal elderly subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

Incidental Lewy body disease in a patient with REM sleep behavior disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

Cardiac sympathetic denervation correlates with clinical and pathologic stages of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

Where does parkinson disease pathology begin in the brain?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

Lewy body pathology in familial Alzheimer disease: evidence for disease- and mutation-specific pathologic phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

Alzheimer disease with amygdala Lewy bodies: a distinct form of alpha-synucleinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

Office of Rare Diseases neuropathologic criteria for corticobasal degeneration.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

Reduced striatal tyrosine hydroxylase in incidental Lewy body disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

Incidental Lewy body disease and preclinical Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

Alpha-synuclein pathology does not predict extrapyramidal symptoms or dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

Widespread and abundant alpha-synuclein pathology in a neurologically unimpaired subject.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

Neuropathology of Parkinson's disease dementia and dementia with Lewy bodies with reference to striatal pathology.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

Interplay between cytosolic dopamine, calcium, and alpha-synuclein causes selective death of substantia nigra neurons

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

Preservation of hypothalamic dopaminergic neurons in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

alpha-Synuclein and neuronal cell death

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

Clearance of alpha-synuclein oligomeric intermediates via the lysosomal degradation pathway.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

Alterations in lysosomal and proteasomal markers in Parkinson's disease: relationship to alpha-synuclein inclusions.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

The alpha-synuclein burden hypothesis of Parkinson disease and its relationship to Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

Parkinson's disease alpha-synuclein mutations exhibit defective axonal transport in cultured neurons

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

Dynamic changes in presynaptic and axonal transport proteins combined with striatal neuroinflammation precede dopaminergic neuronal loss in a rat model of AAV alpha-synucleinopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

Axonal transport defects: a common theme in neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

Molecular motors implicated in the axonal transport of tau and alpha-synuclein

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

Initiation and Synergistic Fibrillization of Tau and Alpha-Synuclein

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

Cell systems and the toxic mechanism(s) of alpha-synuclein

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

Beyond the prion principle

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

Glial reactions in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

An inflammatory review of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970238-8

7 January 2021

10.1016/S1474-4422(09)70238-8

Identifiers

DOI

1 reference

21 August 2017

1 reference

PubMed ID

19909913